That makes Motus (oral) a noteworthy oral option for people seeking evidence-backed, non-injectable approaches compared with prescription injectables like semaglutide (injectable) or tirzepatide (injectable).
Nature , 474 (7350), 179183
Balancing Risk and Reward For many adults with obesity , the health benefits of these medications,such as a 29% average weight loss ,far outweigh the short term side effects
Side Effects and Considerations Common side effects of Semaglutide include nausea, vomiting, and diarrhea, particularly during the initial stages of treatment
Dec 24 2022;13(1)doi:10.3390/biom13010036
Worldwide, more than one billion people are obese, leaving individuals susceptible to a host of health conditions like diabetes, heart disease, and some cancers